Ketamine Assisted Psychotherapy Training Program: KAP Fundamentals Training
Training Program
Live
Oct 25, 2023
–
Oct 29, 2023
3,000
–
3,850
USD
In Person
5 Days
Focus:
Ketamine
Description
Sculpting the ketamine experience deliberately to take advantage of its potentiality is the goal of Ketamine Assisted Psychotherapy (KAP).
An increasing number of clinics run by anesthesiologists and psychiatrists administer ketamine as an intravenous infusion generally over a 40-minute period (the NIMH model) producing varying degrees of mild altered consciousness.
With a series of treatments—usually six over two to three weeks, many patients become better. Given the failure of usual psychiatric methods to improve significant depressions, ketamine’s entry has proven to be a boon to many who suffer with treatment resistant depression (TRD). However, in these medicalized settings, attention to the consciousness and experience of patients is essentially nil. Ketamine is a mind-altering medicine and the experiences engendered are valuable in themselves. The ketamine experience within a psychotherapeutic milieu offers precious opportunities for personal growth and awareness.
In the emerging realm of psychedelic psychotherapy, currently ketamine is the only legally available psychedelic medicine. Embedding the range of its effects in an assisted psychotherapy offers an extraordinary opportunity for rapid change, healing and integration in every-day life. It is essential that practitioners using mind altering substances know through their own experiences of their potential actions, benefits and difficulties. KAP training offers a foundation for utilizing the unique properties of ketamine as a therapeutic methodology. Building KAP practices now will serve to prepare for the advent of the next medicines coming into our tool box. The development of specific therapeutic methodologies for psychedelic psychotherapy and establishing a rigorous standard of care is essential for our work to be great and enduring, beneficial and healing.
We encourage our trainees to join in our expanding international presence through subsequent membership in our Ketamine Psychotherapy Associates, also a program of the Ketamine Research Foundation. KPA furthers the organization of our practices, our understanding of this medicine, is a constant update to our skills and clinical practices and enlarges our horizons by making us aware of the variety of therapeutic strategies and their application to psychedelic psychotherapy.
An increasing number of clinics run by anesthesiologists and psychiatrists administer ketamine as an intravenous infusion generally over a 40-minute period (the NIMH model) producing varying degrees of mild altered consciousness.
With a series of treatments—usually six over two to three weeks, many patients become better. Given the failure of usual psychiatric methods to improve significant depressions, ketamine’s entry has proven to be a boon to many who suffer with treatment resistant depression (TRD). However, in these medicalized settings, attention to the consciousness and experience of patients is essentially nil. Ketamine is a mind-altering medicine and the experiences engendered are valuable in themselves. The ketamine experience within a psychotherapeutic milieu offers precious opportunities for personal growth and awareness.
In the emerging realm of psychedelic psychotherapy, currently ketamine is the only legally available psychedelic medicine. Embedding the range of its effects in an assisted psychotherapy offers an extraordinary opportunity for rapid change, healing and integration in every-day life. It is essential that practitioners using mind altering substances know through their own experiences of their potential actions, benefits and difficulties. KAP training offers a foundation for utilizing the unique properties of ketamine as a therapeutic methodology. Building KAP practices now will serve to prepare for the advent of the next medicines coming into our tool box. The development of specific therapeutic methodologies for psychedelic psychotherapy and establishing a rigorous standard of care is essential for our work to be great and enduring, beneficial and healing.
We encourage our trainees to join in our expanding international presence through subsequent membership in our Ketamine Psychotherapy Associates, also a program of the Ketamine Research Foundation. KPA furthers the organization of our practices, our understanding of this medicine, is a constant update to our skills and clinical practices and enlarges our horizons by making us aware of the variety of therapeutic strategies and their application to psychedelic psychotherapy.
